Pfizer sells swine flu business in China; Emerging World Pharma makes generics for Ghana;

> Pfizer is selling its Chinese swine flu business to meet that country's anti-monopoly law as a condition for approval of the drug giant's merger with Wyeth. Article

> Emerging World Pharma will begin testing and manufacturing generic drugs for the Catholic Diocese of Sunyani, Ghana. Release

> Ubichem Research of Budapest has passed regulatory muster as a cGMP supplier of radio-labeled active pharmaceutical ingredients. Release

> Nutra Pharma has tapped distributor Henry Schein to handle the Nyloxin-branded pain relievers in the U.S. Release

> Ohr Pharmaceutical has received a patent for its method of synthesizing a therapeutic agent, EVIZON, used in several of its compounds, including a treatment for Wet-AMD. Announcement

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.